World's First Malaria Vaccine Distributed in Cameroon
Cameroon, a country in Central Africa with a high malaria burden, has been chosen as the starting point for the vaccine rollout.
Prince Harry returning to UK on eve of Queen Elizabeth II's death anniversary
The Duke of Sussex will attend the WellChild Awards, a charity which he has been patron for 15 years.
PM Sunak appoints leading chief executives to new business council
Prime Minister Rishi Sunak has appointed a new business council that brings the chief executives of major companies into the heart of government to help boost the British economy.
First-ever child deaths reduction prioritising vaccine allocation to prevent malaria in Africa
Around 18 million doses of the first-ever malaria vaccine have been assigned to 12 countries after they proved effective in a pilot study started in 2019.
Businesses funding the Sudan conflict have been sanctioned by the UK government
Six multi-million-dollar companies in the UK, have had their assets frozen to press the parties into a peace treaty after the government imposed new sanctions.
Investment analysis expert reveals surprising similarities between young and old investors
Emma Wall of Hargreaves Lansdown reveals younger investors are more interested in tech investments while the older generation are more likely to invest in pharma companies.
EU watchdog backs Sanofi Covid booster jab
Sanofi said it was ready to start its first shipments of the booster in Britain and the EU, in line with advance contracts for 70 million doses.
Designer Daniel Lee Replaces Riccardo Tisci At Burberry
Burberry Group has appointed Daniel Lee as its new chief creative officer, replacing Riccardo Tisci, who is stepping down after presenting his final runway show for the British luxury brand on Monday.
Haleon Believes It Is Not Liable For Any Potential Zantac Liabilities
Haleon believes it is not liable for any claims that may arise from U.S.
WHO 'strongly advises against' use of two COVID treatments
Two COVID-19 antibody therapies are no longer recommended by the World Health Organization (WHO), on the basis that Omicron and the variant's latest offshoots have likely rendered them obsolete.
Chemical engineer fired for racist, homophobic rant onboard flight
A man hurled racist and homophobic abuse at a fellow passenger onboard an American Airlines flight from Philadelphia to Dallas.
UK first to approve Omicron COVID shot with Moderna go-ahead
Britain has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus.
European shares rise as healthcare rebounds, travel stocks gain
European shares rose on Friday after GSK led a rebound in healthcare stocks, while Flutter fuelled a rally in the travel and leisure sector after an upbeat earnings forecast.
Climate change puts Lyme disease in focus for France's Valneva after COVID blow
With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.
Cheap copies Of GSK's HIV prevention drug could be ready in 2026
British drugmaker GSK has struck a deal to allow low-cost generic versions of its long-acting HIV preventive medicine to be used in the developing world.
Cost of living crisis? Europe's consumers keep spending
Europe's largest consumer-focused firms are seeing no shortage of demand despite a cost-of-living crisis.
Why World's First Malaria Shot Won't Reach Millions Of Children Who Need It
After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a historic milestone that promised to drive back a disease that kills a child every minute.
Sanofi, GSK Variant-specific COVID Shot Found Effective Against Omicron
Late-stage data on an experimental COVID-19 vaccine from Sanofi and GSK has showed the shot confers protection against the Omicron variant of the virus, the companies said on Friday.
US health regulator authorizes Pfizer's Covid pill as Omicron surges
Omicron is better able to bypass prior immunity, and health authorities are urging the public to get boosted with mRNA vaccines
EU agency starts review of France's Sanofi Covid jab
Sanofi and GSK said in May that they would launch final trials after finding their drug "achieved strong rates of neutralising antibody responses" in Phase 2 clinical trials.
US authorizes Moderna vaccine as Italy tightens holiday restrictions
Poorer countries also got a boost Friday when the World Health Organization and partners said vaccines would be distributed early next year to the 190 countries in its Covax initiative.
US approves Pfizer vaccine as millions of doses begin shipping
While lockdowns have brought economic pain, boredom and myriad other woes, the effect on the environment has been more positive.
Nvidia announces plans to build powerful supercomputer called Cambridge-1 in the UK
The Santa Clara, California-based tech company confirmed it is ready to spend around $52 million to develop the Cambridge-1.
Coronavirus vaccine candidates from GlaxoSmithKline, Sanofi begin clinical trials
As with other vaccine candidates, if the outcome of the first two phases is acceptable, the final phase might be scheduled before the end of 2020.
Global virus cases top 18 million as Australian city imposes curfew
Fresh clusters have been reported in countries that had previously brought their outbreaks under control.
UK govt securing 60mn more doses of virus vaccine from two pharmaceutical firms
Once the coronavirus vaccine is approved for use, the British government plans to prioritise those in the social services and healthcare sectors.
Pharma chiefs see coronavirus vaccine by year-end, but challenges 'daunting'
The novel coronavirus has killed more than 355,000 people and infected at least 5.7 million worldwide.
Well-designed workspaces have a direct effect on productivity
Growing number of organisations are realising that they can design their buildings as incubators of creativity and stimulation.
GSK to sell Horlicks as it reviews UK manufacturing options
The 100-year old drink has fallen out of favour with modern British tastes.
Life sciences companies join in NHS funding controversy and threaten to quit UK
Pharmaceutical industry demands government spend extra £20bn a year on NHS.